Cargando…

Magnitude of changes in patient symptom and medication scores in grass allergy immunotherapy trials: dependency on levels of pollen exposure

Detalles Bibliográficos
Autores principales:	Nolte, Hendrik, Durham, Stephen R, Nelson, Harold S, Bernstein, David I, Creticos, Peter, Li, Ziliang, Andersen, Jens, Riis, Bente
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304083/ http://dx.doi.org/10.1186/1710-1492-10-S2-A33

Ejemplares similares

Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposure
por: Durham, S R, et al.
Publicado: (2014)

Efficacy of Timothy grass allergy immunotherapy tablet (AIT) treatment in Canadian children and adults with grass pollen-induced allergic rhinoconjunctivitis (ARC)
por: Hebert, Jacques, et al.
Publicado: (2011)

Efficacy and safety of MK-7243: a grass allergy sublingual immunotherapy tablet evaluated in Canadian adults and children
por: Hébert, Jacques, et al.
Publicado: (2014)

The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children
por: Hébert, Jacques, et al.
Publicado: (2014)

Efficacy and safety of standardized short ragweed sublingual immunotherapy tablet (SLIT-T) treatment in Canadian subjects with ragweed pollen-induced rhinitis with or without conjunctivitis
por: Blaiss, Michael, et al.
Publicado: (2014)

161 Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in us Adults With Grass-Pollen Allergic Rhinoconjunctivitis
por: Cox, Linda, et al.
Publicado: (2012)

A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma
por: Murphy, Kevin, et al.
Publicado: (2013)

The effect of the ragweed sublingual immunotherapy tablet MK-3641 on rescue medication use
por: Gawchik, Sandra, et al.
Publicado: (2014)

Efficiacy of injection specific immunotherapy for grass pollen seasonal allergic rhinitis
por: Wasilewska, Eliza, et al.
Publicado: (2015)

Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis
por: Kim, Harold, et al.
Publicado: (2014)

176 Sublingual Immunotherapy for Grass Pollen Allergy in Children: A Systematic Review and Meta-Analysis
por: Bryson, Rebecca
Publicado: (2012)

Plant Food Allergy Improvement after Grass Pollen Sublingual Immunotherapy: A Case Series
por: Furci, Fabiana, et al.
Publicado: (2021)

Tree pollen allergy in Southwestern Ontario
por: Tsai, Gina, et al.
Publicado: (2012)

4 The Risk of Severe Treatment Related Adverse Events is Significantly Lower in Children Compared to Adults When Treated With Standardized Timothy Grass Allergy Immunotherapy Tablets: Post Hoc Analysis of 7 Clinical Trials
por: Andersen, Jens Strodl, et al.
Publicado: (2012)

Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy
por: Zieglmayer, Petra, et al.
Publicado: (2016)

Linear Epitope Binding Patterns of Grass Pollen-Specific Antibodies in Allergy and in Response to Allergen-Specific Immunotherapy
por: Thörnqvist, Linnea, et al.
Publicado: (2022)

Management of Grass Pollen Allergy with 5-Grass Pollen Tablet: Results of a 2-Year Real-Life Study
por: Shah-Hosseini, Kija, et al.
Publicado: (2017)

Treatment of grass pollen allergy: focus on a standardized grass allergen extract – Grazax(®)
por: Calderón, Moisés, et al.
Publicado: (2008)

Allergy immunotherapy prescribing trends for grass pollen-induced allergic rhinitis in Germany: a retrospective cohort analysis
por: McDonell, Amanda L., et al.
Publicado: (2015)

Two grass pollen tablets commercially available for allergy immunotherapy display different IgE epitope repertoires
por: Batard, Thierry, et al.
Publicado: (2019)

Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge
por: Scadding, G. W., et al.
Publicado: (2015)

Induction of Bronchial Tolerance After 1 Cycle of Monophosphoryl-A-Adjuvanted Specific Immunotherapy in Children With Grass Pollen Allergies
por: Rosewich, Martin, et al.
Publicado: (2016)

Grass pollen allergy in children and adolescents-symptoms, health related quality of life and the value of pollen prognosis
por: Kiotseridis, Hampus, et al.
Publicado: (2013)

Chinese Birch Pollen Allergy and Immunotherapy in Mice
por: Xie, Zhijuan, et al.
Publicado: (2019)

Effect of Pollen-Specific Sublingual Immunotherapy on Oral Allergy Syndrome: An Observational Study
por: Bergmann, Karl-Christian, et al.
Publicado: (2008)

Assessment of Google Trends terms reporting allergies and the grass pollen season in Ukraine
por: Kaidashev, Igor, et al.
Publicado: (2020)

Are Markers of Allergic Inflammation in Grass Pollen Allergy Influenced by H1 Antihistamines?
por: Bocsan, Ioana Corina, et al.
Publicado: (2021)

Efficacy of short-ragweed sublingual immunotherapy tablet MK-3641 in monosensitized and polysensitized subjects
por: Bernstein, David I, et al.
Publicado: (2014)

A systematic review of randomised controlled trials, non-randomised controlled trials and observational studies to ascertain the role of pollen-specific immunotherapy in improving clinical outcomes in pollen-food (ORAL ALLERGY) syndrome
por: Bowry, Priya
Publicado: (2015)

Evaluation of subcutaneous immunotherapy with birch pollen extract for pollen-food allergy syndrome
por: Hamada, Masaaki, et al.
Publicado: (2021)

Determining the minimal important differences in the RQLQ score with grass and tree allergy immunotherapy versus placebo in adults with moderate‐to‐severe allergy
por: Blaiss, Michael S., et al.
Publicado: (2022)

Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
por: Focke-Tejkl, Margarete, et al.
Publicado: (2015)

Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection
por: Cornelius, Carolin, et al.
Publicado: (2016)

Diagnosis of nasal and eye allergies: the Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) patient survey
por: Blaiss, Michael, et al.
Publicado: (2014)

Personalized Pollen Monitoring and Symptom Scores: A Feasibility Study in Grass Pollen Allergic Patients
por: de Weger, Letty A., et al.
Publicado: (2021)

Intradermal grass pollen immunotherapy increases T(H)2 and IgE responses and worsens respiratory allergic symptoms
por: Slovick, Anna, et al.
Publicado: (2017)

Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
por: Lombardi, Carlo, et al.
Publicado: (2017)

Relative potency in SPT of solution and tablet SLIT allergen extracts of Timothy grass pollen from 2 European manufacturers compared to a US reference extract
por: Larenas-Linnemann, Désirée, et al.
Publicado: (2015)

Oral immunotherapy for milk allergy: a systematic review
por: Yeung, Joanne P, et al.
Publicado: (2012)

An observational cohort study of the use of five-grass-pollen extract sublingual immunotherapy during the 2015 pollen season in France
por: Blin, Patrick, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p6acu4lfi7t9hluks9q1qhgftv